MYLOTARG

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: 68e6392e85f86d23
Drug Approval Canada Name: MYLOTARG
Product Name: MYLOTARG
Status: Marketed
Status Date: 2020-03-11
Original Market Date: 2020-03-11
Din: 02494388
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intravenous
Schedule: Prescription , Schedule D
Ahfs: 10:00.00
Atc Original: L01FX02 GEMTUZUMAB OZOGAMICIN
Atc Name: l 01 fx 02
Aig Number: 0161991001
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

GEMTUZUMAB OZOGAMICIN

4.5 MG / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

68e6392e85f86d23

Type

Standard